Capsugel Manufactures Inhaled Biotherapy
By

Capsugel has manufactured Phase II clinical trial supplies for a dry powder inhalation (DPI) formulation that delivers biotherapeutics to the lung. The supplies were manufactured by Bend Research, part of Capsugel's Dosage Form Solutions business unit. Utilizing a combination of unique formulation, particle engineering and spray-drying processing methods, the inhaled dry-powder biotherapeutic is the first inhalation delivery therapy to be manufactured to Phase II scale at the company's clinical trial manufacturing (CTM) facility in Bend, Oregon.

Source: Capsugel

Leave a Reply

Your email address will not be published. Required fields are marked *